Purification and characterization of a canine liver phenol sulfotransferase.

Species differences in the metabolism of xenobiotics can present significant problems for safety and efficacy assessment during the development of new pharmaceutical agents. Identification of animal models for human metabolism and/or toxicology of any particular compound would significantly reduce the extent and cost of animal testing of novel candidate pharmaceuticals. Sulfation is an important pathway for metabolism of xenobiotics and potent endogenous compounds and is catalyzed by members of the sulfotransferase enzyme family. We have purified a phenol sulfotransferase from male dog liver cytosol which sulfates simple phenolic compounds such as 1-naphthol and 4-nitrophenol. On SDS-polyacrylamide gel electrophoresis, the protein had a subunit molecular weight of approximately 32,000 Da and was 34,200 Da by electrospray mass spectrometry. Immunoblot analysis with an anti-peptide antibody specific for the human phenol-sulfating form of phenol sulfotransferase (P-PST, 1A1) suggested the protein was highly homologous to the human P-PST enzyme. This was supported by amino acid sequence analysis of four peptides derived from the purified enzyme and by comparison with sequences of other phenol sulfotransferases, which showed the highest identity with human and monkey orthologs. Our data illustrate the high degree of conservation of phenol sulfotransferases across mammalian species and suggest that this dog liver enzyme is more closely related to the human P-PST than equivalent proteins in rats and mice.

[1]  M. Coughtrie Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism? , 1996, Human & experimental toxicology.

[2]  C. Zwieb,et al.  Purification, Characterization, and Molecular Cloning of A Novel Rat Liver Dopa/Tyrosine Sulfotransferase (*) , 1995, The Journal of Biological Chemistry.

[3]  R. Kato,et al.  Primary structures and properties of two related forms of aryl sulfotransferases in human liver. , 1995, Pharmacogenetics.

[4]  S. Binkley,et al.  Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[5]  H. Glatt,et al.  Human platelet phenolsulfotransferases: cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. , 1995, Biochemical and biophysical research communications.

[6]  R. Kato,et al.  Structural similarity and diversity of sulfotransferases. , 1994, Chemico-biological interactions.

[7]  A. Jones,et al.  The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein. , 1993, The Biochemical journal.

[8]  R. Hume,et al.  Immunochemical characterisation of a dehydroepiandrosterone sulfotransferase in rats and humans. , 1993, European journal of biochemistry.

[9]  M. Coughtrie,et al.  Purification and immunochemical characterization of a male-specific rat liver oestrogen sulphotransferase. , 1993, The Biochemical journal.

[10]  M. Coughtrie,et al.  Purification and immunochemical characterization of a rat liver sulphotransferase conjugating paracetamol. , 1990, Biochemical pharmacology.

[11]  T. Walle,et al.  Stereoselective sulfation of R,S-4'-hydroxypropranolol by canine hepatic cytosol and partially purified phenolsulfotransferases. , 1989, The Journal of pharmacology and experimental therapeutics.

[12]  B. Burchell,et al.  The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes. , 1988, Molecular pharmacology.

[13]  S. Carrière,et al.  Partial purification and characterization of two isoenzymes involved in the sulfurylation of catecholamines. , 1982, Biochemical and biophysical research communications.

[14]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[16]  A. Petrin [Pharmacokinetics of drugs in the elderly]. , 1974, International journal of clinical pharmacology, therapy and toxicology.

[17]  J. Meek,et al.  Rat brain phenolsulfotransferase: partial purification and some properties. , 1973, Biochimica et biophysica acta.

[18]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[19]  H. Glatt,et al.  Design, production and characterization of antibodies discriminating between the phenol- and monoamine-sulphating forms of human phenol sulphotransferase. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  M. McManus,et al.  CDNA CLONING AND EXPRESSION AND EXPRESSION OF A NEW FORM OF HUMAN ARYL SULFOTRANSFERASE , 1996 .

[21]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. , 1992, Biotechnology.

[22]  D. Smith,et al.  Species differences in metabolism and pharmacokinetics: are we close to an understanding? , 1991, Drug metabolism reviews.

[23]  C. Falany Molecular enzymology of human liver cytosolic sulfotransferases. , 1991, Trends in pharmacological sciences.

[24]  R. Weinshilboum Sulfotransferase pharmacogenetics. , 1990, Pharmacology & therapeutics.

[25]  W. Jakoby The enzymes of detoxication. , 1983, Transactions of the New York Academy of Sciences.

[26]  O. Pelkonen Biotransformation of xenobiotics in the fetus. , 1980, Pharmacology & therapeutics.

[27]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .